Boyd Watterson Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
9,360
-310
-3% -$8.11K 0.06% 127
2026
Q1
$272K Sell
9,670
-3,905
-29% -$104K 0.08% 114
2025
Q4
$338K Buy
13,575
+367
+3% +$9.26K 0.1% 114
2025
Q3
$337K Sell
13,208
-670
-5% -$16.5K 0.1% 111
2025
Q2
$336K Sell
13,878
-7,624
-35% -$178K 0.11% 111
2025
Q1
$545K Sell
21,502
-12
-0.1% -$314 0.17% 94
2024
Q4
$571K Sell
21,514
-31
-0.1% -$841 0.16% 90
2024
Q3
$624K Sell
21,545
-51
-0.2% -$1.49K 0.17% 84
2024
Q2
$604K Sell
21,596
-7,500
-26% -$206K 0.17% 82
2024
Q1
$807K Sell
29,096
-11,700
-29% -$325K 0.29% 65
2023
Q4
$1.17M Sell
40,796
-20,052
-33% -$606K 0.46% 53
2023
Q3
$2.02M Hold
60,848
0.88% 32
2023
Q2
$2.23M Buy
60,848
+19
+0% +$740 0.89% 30
2023
Q1
$2.48M Buy
60,829
+17
+0% +$734 1.01% 27
2022
Q4
$3.12M Sell
60,812
-30
-0% -$1.44K 1.28% 21
2022
Q3
$2.66M Hold
60,842
1.21% 22
2022
Q2
$3.19M Sell
60,842
-56
-0.1% -$2.85K 1.36% 18
2022
Q1
$3.15M Buy
60,898
+27
+0% +$1.4K 1.15% 22
2021
Q4
$3.59M Sell
60,871
-14
-0% -$694 1.2% 18
2021
Q3
$2.62M Sell
60,885
-9
-0% -$399 0.97% 31
2021
Q2
$2.38M Buy
60,894
+93
+0.2% +$3.62K 0.96% 28
2021
Q1
$2.2M Sell
60,801
-146
-0.2% -$5.18K 0.96% 30
2020
Q4
$2.24M Sell
60,947
-3,714
-6% -$136K 1.07% 27
2020
Q3
$2.25M Sell
64,661
-573
-0.9% -$20.1K 1.24% 23
2020
Q2
$2.02M Sell
65,234
-527
-0.8% -$17.9K 1.37% 19
2020
Q1
$2.04M Sell
65,761
-35
-0.1% -$1.19K 1.67% 14
2019
Q4
$2.45M Sell
65,796
-422
-0.6% -$15K 1.61% 17
2019
Q3
$2.26M Sell
66,218
-10,540
-14% -$383K 1.58% 17
2019
Q2
$3.15M Sell
76,758
-871
-1% -$34.6K 2.15% 7
2019
Q1
$3.13M Buy
77,629
+698
+0.9% +$28K 1.97% 9
2018
Q4
$3.19M Sell
76,931
-279
-0.4% -$11.6K 2.33% 7
2018
Q3
$3.23M Sell
77,210
-208
-0.3% -$8.01K 1.85% 14
2018
Q2
$2.67M Sell
77,418
-10,413
-12% -$356K 1.53% 17
2018
Q1
$2.96M Buy
87,831
+8,928
+11% +$307K 1.47% 17
2017
Q4
$2.71M Sell
78,903
-737
-0.9% -$25.1K 1.31% 19
2017
Q3
$2.7M Sell
79,640
-9,878
-11% -$317K 1.33% 17
2017
Q2
$2.85M Sell
89,518
-5,611
-6% -$177K 1.46% 15
2017
Q1
$3.09M Sell
95,129
-218
-0.2% -$6.87K 1.55% 12
2016
Q4
$2.94M Sell
95,347
-2,617
-3% -$79.9K 1.56% 13
2016
Q3
$3.15M Sell
97,964
-156
-0.2% -$5.22K 1.54% 10
2016
Q2
$3.28M Sell
98,120
-1,683
-2% -$53.7K 1.56% 10
2016
Q1
$2.81M Sell
99,803
-6,284
-6% -$179K 1.36% 15
2015
Q4
$3.25M Sell
106,087
-10,385
-9% -$327K 1.55% 11
2015
Q3
$3.47M Sell
116,472
-2,842
-2% -$91.1K 1.48% 16
2015
Q2
$3.8M Buy
119,314
+418
+0.4% +$13.6K 1.48% 17
2015
Q1
$3.92M Sell
118,896
-1,910
-2% -$60.7K 1.57% 14
2014
Q4
$3.57M Buy
120,806
+3,371
+3% +$96.7K 1.52% 15
2014
Q3
$3.29M Sell
117,435
-44,150
-27% -$1.24M 1.44% 17
2014
Q2
$4.55M Sell
161,585
-4,479
-3% -$128K 1.97% 10
2014
Q1
$5.06M Sell
166,064
-4,317
-3% -$129K 2.36% 7
2013
Q4
$4.95M Sell
170,381
-2,556
-1% -$74.4K 2.31% 7
2013
Q3
$4.71M Buy
172,937
+1,225
+0.7% +$33.3K 2.25% 8
2013
Q2
$4.56M Buy
+171,712
New +$4.74M 2.32% 9

Other funds holding PFE

Boyd Watterson Asset Management's PFE Position: Q2 2026 in Review

Boyd Watterson Asset Management reduced its Pfizer (PFE) stake by 3.2% in Q2 2026, selling an estimated $8.11K and leaving 9,360 shares worth $225K. The position accounts for 0.06% of the portfolio, ranked #127.

Boyd Watterson Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.06M in Q1 2014. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Boyd Watterson Asset Management held 9,360 shares of Pfizer worth $225K as of Q2 2026.
  • Boyd Watterson Asset Management sold 310 Pfizer shares in Q2 2026, an estimated $8.11K.
  • Pfizer made up 0.06% of Boyd Watterson Asset Management's portfolio in Q2 2026, its #127 holding.
  • Boyd Watterson Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Boyd Watterson Asset Management's Pfizer position peaked at $5.06M in Q1 2014.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.